+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pruritus Drug"

From
Uremic Pruritus - Epidemiology Forecast - 2032 - Product Thumbnail Image

Uremic Pruritus - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pruritus Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pruritus Drugs Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 200 Pages
  • Global
From
From
From
US Pruritus Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Pruritus Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Loading Indicator

Pruritus, or itching, is a common symptom of many skin conditions and can be treated with dermatological drugs. These drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and can include corticosteroids, calcineurin inhibitors, and antihistamines. Systemic drugs are taken orally or injected and can include anticonvulsants, antidepressants, and opioids. The pruritus drug market is a subset of the larger dermatological drug market. It is composed of a variety of drugs used to treat itching, including both topical and systemic treatments. These drugs are used to treat a wide range of skin conditions, from eczema and psoriasis to allergic reactions and insect bites. Some companies in the pruritus drug market include Pfizer, Novartis, GlaxoSmithKline, Sanofi, and Merck. Show Less Read more